The MIR142 mutations identified in AML patients, exclusively co-occurred with IDH mutations in the TCGA cohort, and in one patient from the cohort of AML and MDS patients described by Thol et al.1,8. This evidence concerns the gene MIR142 and myelodysplastic syndrome.